7-70790590-GCCACCACCACCACCACCA-GCCACCACCA
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_015570.4(AUTS2):c.3392_3400delACCACCACC(p.His1131_His1133del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000284 in 1,600,840 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 0 hom. )
Consequence
AUTS2
NM_015570.4 disruptive_inframe_deletion
NM_015570.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.22
Genes affected
AUTS2 (HGNC:14262): (activator of transcription and developmental regulator AUTS2) This gene has been implicated in neurodevelopment and as a candidate gene for numerous neurological disorders, including autism spectrum disorders, intellectual disability, and developmental delay. Mutations in this gene have also been associated with non-neurological disorders, such as acute lymphoblastic leukemia, aging of the skin, early-onset androgenetic alopecia, and certain cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 7-70790590-GCCACCACCA-G is Benign according to our data. Variant chr7-70790590-GCCACCACCA-G is described in ClinVar as [Likely_benign]. Clinvar id is 787554.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000303 (46/151886) while in subpopulation AFR AF= 0.000289 (12/41476). AF 95% confidence interval is 0.000167. There are 0 homozygotes in gnomad4. There are 25 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 46 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AUTS2 | NM_015570.4 | c.3392_3400delACCACCACC | p.His1131_His1133del | disruptive_inframe_deletion | Exon 19 of 19 | ENST00000342771.10 | NP_056385.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000303 AC: 46AN: 151772Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
46
AN:
151772
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000363 AC: 69AN: 189948Hom.: 1 AF XY: 0.000407 AC XY: 42AN XY: 103280
GnomAD3 exomes
AF:
AC:
69
AN:
189948
Hom.:
AF XY:
AC XY:
42
AN XY:
103280
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000282 AC: 408AN: 1448954Hom.: 0 AF XY: 0.000295 AC XY: 212AN XY: 719808
GnomAD4 exome
AF:
AC:
408
AN:
1448954
Hom.:
AF XY:
AC XY:
212
AN XY:
719808
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000303 AC: 46AN: 151886Hom.: 0 Cov.: 32 AF XY: 0.000337 AC XY: 25AN XY: 74206
GnomAD4 genome
AF:
AC:
46
AN:
151886
Hom.:
Cov.:
32
AF XY:
AC XY:
25
AN XY:
74206
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jul 07, 2020
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
AUTS2: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at